Taiko Pharmaceutical Co.,Ltd. (TYO:4574)

Japan flag Japan · Delayed Price · Currency is JPY
277.00
-3.00 (-1.07%)
Jul 16, 2025, 3:30 PM JST
-42.05%
Market Cap14.05B
Revenue (ttm)6.07B
Net Income (ttm)718.00M
Shares Out50.19M
EPS (ttm)14.30
PE Ratio19.57
Forward PE48.70
Dividendn/a
Ex-Dividend Daten/a
Volume176,100
Average Volume1,817,960
Open281.00
Previous Close280.00
Day's Range277.00 - 282.00
52-Week Range228.00 - 495.00
Beta0.18
RSI47.25
Earnings DateAug 8, 2025

About Taiko Pharmaceutical

Taiko Pharmaceutical Co.,Ltd. manufactures and sells over-the-counter (OTC) medicines in Japan and internationally. The company provides OTC medicines for the treatment of loose stools, diarrhea, vomiting, food and water poisoning symptoms, and toothache; and quasi-drugs for regulation of intestinal movements, relieves stomach distention, loose stools, and constipation. It manufactures and sells infection control products. Taiko Pharmaceutical Co.,Ltd. exports its products. The company was incorporated in 1946 and is headquartered in Osaka, Jap... [Read more]

Sector Healthcare
Founded 1946
Employees 214
Stock Exchange Tokyo Stock Exchange
Ticker Symbol 4574
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.